Compare Kaspa (KAS) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kaspa vs Mira — how do they compare? Kaspa trades at Rp449.13 (market cap Rp12,44T, Rp98,57M 24h volume), while Mira trades at Rp700.16 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Kaspa is far larger — about 54939.7× Mira's market cap, and Kaspa's circulating supply is 27,6B / 28,7B KAS (97%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Kaspa for 42 Days and Mira for 22 Days on average.
| KAS | MIRA | |
|---|---|---|
Market Cap | Rp12,44T | Rp226,43M |
Volume (24h) | Rp98,57M | Rp101,47M |
Circulating Supply | 27,6B / 28,7B KAS (97%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 42 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kaspa is trading at Rp448.25 with a market cap of Rp12.45T, showing a bearish technical signal across moving averages and oscillators. The price is near support at S1 (Rp447) with RSI_12 indicating potential oversold conditions. No major protocol updates or ecosystem developments were noted recently, and the circulating supply is high at 97% of the max supply of 28.7M KAS.
The overall outlook is cautious due to bearish technicals and lack of positive catalysts. Key opportunities include potential rebounds from oversold levels, but risks involve continued downward pressure, low liquidity, and crypto market volatility. Investors should monitor support levels and broader market sentiment.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kaspa
Kaspa is a fast and scalable Layer-1 cryptocurrency built on a proof-of-work model, powered by the GHOSTDAG protocol. This protocol allows multiple blocks to coexist in a blockDAG structure. Kaspa can process 10 blocks per second, with plans to scale to 100 BPS, providing near-instant confirmation times. Designed for accessibility and decentralization, Kaspa runs smoothly on standard personal computers and supports future Layer-2 solutions for scalable and secure applications.
Read more on KAS →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
